Search For "biotech"
Bharat Biotech applies for market authorisation from DCGI for five arms in
Updated : 3 years, 6 months ago IST
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
Read More
Bharat Biotech-made iNCOVACC becomes world's first intranasal COVID vaccin
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
Read More
Avesthagen consolidates its position with an innovative platform for preci
Updated : 3 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 6 (ANI/NewsVoir): Avesthagen Limited, India's pioneering Systems biology genomics company, has launched AVGEN Diagnostics, the first fully integrated end-to-end personalized genetic testing service. The innovative platform employs the latest in NGS seq
Read More
COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI app
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
Read More
Sri Lanka's audit report calls for action against officials, Chinese firm
Updated : 3 years, 6 months ago IST
Colombo [Sri Lanka], September 5 (ANI): After the fertilizer deal between Sri Lanka and China caused the island nation's exchequer a loss of USD 6.9 million as the stock of fertilizer was rejected in December 2021 over reports that it contained harmful bacteria, Sri Lanka's audit report call
Read More
Cost of cervical cancer vaccine Cervavac will be between Rs 200-400: Adar
Updated : 3 years, 6 months ago IST
New Delhi [India], September 1 (ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday.
Read More
India's first vaccine against cervical cancer to be launched tomorrow
Updated : 3 years, 6 months ago IST
New Delhi [India], August 31 (ANI): The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India's first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer on September 1, official sources told ANI.
Read More
China pushes Sri Lanka to continue with organic fertilizer project despite
Updated : 3 years, 6 months ago IST
Colombo [Sri Lanka], August 29 (ANI): After the Sri Lankan government rejected an order of organic fertilizer from a Chinese company on the issue of the presence of harmful bacteria, Beijing is pressuring Colombo to continue with its organic fertilizer project.
Read More
Sri Lanka suffered loss of USD 6.9 mn in Chinese fertilizer deal
Updated : 3 years, 6 months ago IST
Colombo [Sri Lanka], August 25 (ANI): The fertilizer deal between Sri Lanka and China has caused the island nation's exchequer a loss of USD 6.9 million as the stock of fertilizer was rejected in December 2021 over reports that it contained harmful bacteria.
Read More
Nigeria introduces Bharat Biotech's Rotavac vaccine to immunise children
Updated : 3 years, 6 months ago IST
Hyderabad (Telangana) [India], August 24 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer, on Wednesday announced that its rotavirus oral vaccine ROTAVAC has been introduced to immunise its children from the life-threatening diarrhoeal
Read More
From Electric Vehicles to Genetic Engineering: This edtech platform has re
Updated : 3 years, 7 months ago IST
Bangalore (Karnataka) [India], August 17 (ANI/NewsVoir): Advancements in Technology have reduced physical distances around the globe while also blurring national boundaries. Industry exposure is critical during the student phase since it enables hands-on experience rather than theoretical le
Read More
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 7 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More